- Investing Ideas
- /
- German Undervalued Stocks Based On Cash Flows
German Undervalued Stocks Based On Cash Flows
Results
26
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
26 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
VTSC | €56.45 | -4.8% | -26.2% | €2.3b | €74.72 | PB0.8x | E62.7% | 0.4% | Automobiles | ||
SBS | €41.30 | -1.4% | -18.2% | €502.0m | €42.33 | PE41.3x | E21.9% | 1.3% | Healthcare | ||
HNL | €18.05 | 3.7% | -19.1% | €109.4m | €25.20 | PS1.1x | E121.4% | n/a | Capital Goods | ||
STM | €42.45 | -3.2% | -17.1% | €1.0b | €63.44 | PE14.3x | E20.5% | 4.1% | Capital Goods | ||
RTV | €2.48 | -1.6% | -3.9% | €37.9m | €2.80 | PS13.5x | E116.8% | n/a | Media | ||
CHG | €24.00 | -0.8% | 67.8% | €469.2m | €27.00 | PS6.6x | E73.4% | n/a | Healthcare | ||
ISHA | €2.00 | -1.0% | 2.6% | €29.2m | €2.70 | PB2.7x | E86.2% | n/a | Software | ||
TTR1 | €16.50 | -3.5% | -33.2% | €114.0m | €21.50 | PE17.8x | E29.4% | 3.8% | Capital Goods | ||
MTX | €257.90 | 4.1% | 22.1% | €13.9b | €250.14 | PS2.5x | E34.9% | 0.8% | Capital Goods | ||
AEIN | €16.40 | -3.2% | -32.2% | €187.7m | €32.63 | PE14x | E25.2% | 3.0% | Software | ||
SANT | €19.52 | -0.5% | 0.8% | €1.2b | €30.42 | PE16x | E21.1% | 2.6% | Software | ||
RSL2 | €18.60 | 1.1% | -16.2% | €119.8m | €30.00 | PB1.7x | E58.9% | 0% | Capital Goods | ||
E4C | €12.75 | -1.2% | -33.9% | €44.8m | €40.50 | PE29.5x | E46.7% | 3.7% | Telecom | ||
ADS | €233.00 | 2.6% | 25.9% | €41.6b | €233.50 | PE489.4x | E41.0% | 0.3% | Consumer Durables | ||
BSL | €9.98 | -5.1% | -35.4% | €306.8m | €15.70 | PS1.6x | E84.0% | 0% | Tech | ||
R3NK | €24.74 | -0.5% | n/a | €2.4b | €31.88 | PE78.5x | E32.8% | 1.2% | Capital Goods | ||
V3S | €10.70 | 0.9% | 94.5% | €86.2m | €10.25 | PS2.3x | E118.7% | 0% | Tech | ||
LPK | €8.06 | 2.3% | 0% | €197.3m | €12.05 | PE87x | E70.5% | n/a | Tech | ||
M12 | €15.35 | -5.0% | 94.3% | €281.1m | €27.50 | PE27.4x | E24.4% | 3.3% | Healthcare | ||
GXI | €93.75 | -2.0% | -13.2% | €3.2b | €134.06 | PE28.1x | E22.2% | 1.3% | Pharmaceuticals & Biotech | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
SAP | €195.78 | 7.9% | 58.4% | €228.4b | €207.92 | PE89.2x | E37.7% | 1.1% | Software | ||
MBB | €103.80 | -0.4% | 31.7% | €593.4m | €123.00 | PE32.1x | E33.5% | 1.0% | Capital Goods | ||
SJJ | €12.90 | 9.3% | 52.8% | €135.5m | €19.75 | PS1.4x | E111.5% | 0% | Software |